Overview


Alternating Electric Field Tumor Treatment, also known as Tumor Treating Fields (TTFields) therapy, is an innovative and non-invasive cancer treatment modality that uses low-intensity, intermediate-frequency electric fields to disrupt cancer cell division and growth. This treatment is primarily used in the management of certain solid tumor cancers, particularly glioblastoma multiforme (GBM), a highly aggressive and malignant brain tumor. The therapy involves the use of a medical device called an Optune™, which delivers the alternating electric fields directly to the tumor site through arrays of insulated electrodes placed on the patient's scalp. These electric fields create forces that interfere with cancer cells' normal division and replication during their mitosis phase, leading to cellular disruption and ultimately causing cancer cell death.

TTFields therapy is designed to be used in combination with standard cancer therapy such as surgery, radiation therapy, and others. The addition of TTFields therapy has shown promising results in improving overall survival and progression-free survival rates for patients with GBM, and it has been approved by regulatory authorities in various regions for this specific indication.

FutureWise Market Research has published a report that provides an insightful analysis of alternating electric field tumor treatment market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the alternating electric field tumor treatment market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.
  • Novocure

(Note: The list of the major players will be updated with the latest market scenario and trends)

One of the main drivers is the demonstrated effectiveness of this therapy in the treatment of glioblastoma multiforme (GBM), a challenging and aggressive brain tumor. Clinical studies have shown that the addition of TTFields therapy to standard treatments can significantly improve overall survival and progression-free survival rates in GBM patients, making it a promising treatment option for this indication. Another important factor contributing to the market growth is the non-invasive nature of TTFields therapy. Unlike traditional cancer treatments, TTFields therapy is applied externally through a portable medical device placed on the patient's scalp, making it well-tolerated and suitable for patients who may not be candidates for more invasive therapies. Moreover, TTFields therapy is associated with minimal systemic side effects as it targets cancer cells specifically, leaving healthy tissues relatively unaffected. This safety profile makes it an attractive option, especially for elderly or frail patients. Additionally, as technology advances, there is an opportunity to develop more user-friendly and advanced TTFields devices. Innovations in device design, such as miniaturization and wireless capabilities, can enhance patient comfort and compliance with TTFields therapy. A more portable and convenient device may lead to greater patient acceptance and broader adoption of this treatment modality.Furthermore, exploring the use of TTFields therapy in combination with targeted therapies or precision medicine approaches is another avenue for advancement. Tailoring TTFields treatment to a patient's specific molecular profile and tumor characteristics may further optimize its therapeutic benefits and improve patient outcomes. However, the lack of long-term data on the sustained effects of TTFields therapy. As TTFields therapy is a relatively new treatment modality, there is a need for more extended follow-up studies to understand its long-term impact on patient outcomes, including overall survival and quality of life. cost considerations can also be a limitation for some patients and healthcare systems. The TTFields device and its maintenance costs can be a financial burden for certain individuals, especially in regions with limited healthcare resources or inadequate insurance coverage.

By Type

  • Low Frequency
  • Intermediate Frequency

By Application

  • Hospitals
  • Clinics
  • Cancer and Radiation Therapy Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The region's robust healthcare infrastructure, exemplified by advanced medical facilities and a skilled healthcare workforce, has paved the way for the widespread adoption of innovative therapies such as TTFields. Additionally, the proactive regulatory environment and well-established clinical research ecosystem have facilitated swift approvals and the integration of TTFields into standard treatment protocols. The collaborative synergy between research institutions, medical practitioners, and industry leaders has fostered an environment of constant innovation and refinement, further enhancing the effectiveness of TTFields.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Alternating Electric Field Tumor Treatment Market By Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction

    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology

    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Alternating Electric Field Tumor Treatment Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Alternating Electric Field Tumor Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Alternating Electric Field Tumor Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Alternating Electric Field Tumor Treatment Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Low Frequency
        2. Intermediate Frequency

  • 8.   Alternating Electric Field Tumor Treatment Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospitals
        2. Clinics
        3. Cancer and Radiation Therapy Centers
        4. Others

  • 9.   North America Alternating Electric Field Tumor Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Alternating Electric Field Tumor Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Alternating Electric Field Tumor Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Alternating Electric Field Tumor Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Novocure
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11